Browse
We’re here to help

Find guidance on Author Services

Login | Register

Login
Register

Cart Add to Cart

Search
Browse
We’re here to help

Find guidance on Author Services

Home
All Journals
Expert Opinion on Drug Safety
List of Issues
Volume 22, Issue 2

Expert Opinion on Drug Safety

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

Journal metrics
Aims & scope
Journal information
Editorial board
News & calls for papers
Advertising information

Latest articles
Current issue
All volumes & issues
Special issues
Open access articles
Most read articles
Most cited articles

New content alerts
RSS

Subscription options & pricing

Buy a subscription

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Register a free Taylor & Francis Online account today to boost your research and gain these benefits:

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Register now or learn more

Expert Opinion on Drug Safety, Volume 22, Issue 2 (2023)

Browse this journal

Latest articles
Current issue
List of issues
Special issues
Open access articles
Most read articles
Most cited articles

Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Opinion on Drug Safety, Volume 22, Issue 2 (2023)

See all volumes and issues

Vol 23, 2024 Volume 22, 2023 Vol 21, 2022 Vol 20, 2021 Vol 19, 2020 Vol 18, 2019 Vol 17, 2018 Vol 16, 2017 Vol 15, 2016 Vol 14, 2015 Vol 13, 2014 Vol 12, 2013 Vol 11, 2012 Vol 10, 2011 Vol 9, 2010 Vol 8, 2009 Vol 7, 2008 Vol 6, 2007 Vol 5, 2006 Vol 4, 2005 Vol 3, 2004 Vol 2, 2003 Vol 1, 2002

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Editorial

The safety and efficacy of interleukin 11 for radiation injury

Vijay K. Singh & Thomas M Seed

Pages: 105-109

Published online: 03 Mar 2023

First Page PreviewforThe safety and efficacy of interleukin 11 for radiation injury | Full Text | References | PDF (327.4 KB) | EPUB

798 Views
0 CrossRef citations
0Altmetric

Free Access

Editorial

Impact of regulatory safety warnings and restrictions on drug treatment of epilepsy

Amanda W. Pong, Ivana Tyrlikova, Alexander J. Giermek & Pavel Klein

Pages: 111-114

Published online: 09 Mar 2023

First Page PreviewforImpact of regulatory safety warnings and restrictions on drug treatment of epilepsy | Full Text | References | PDF (170.5 KB) | EPUB

947 Views
0 CrossRef citations
0Altmetric

Free Access

Editorial

Medication errors during a pandemic: what have we learnt?

Ahmad Z. Al Meslamani

Pages: 115-118

Published online: 22 Feb 2023

First Page PreviewforMedication errors during a pandemic: what have we learnt? | Full Text | References | PDF (191.9 KB) | EPUB

2100 Views
0 CrossRef citations
0Altmetric

Free Access

Review

Article

Safety and cardiometabolic efficacy of novel antidiabetic drugs

Liana Michaud, Matthew Seplowe, Juliet Meir & Wilbert S. Aronow

Pages: 119-124

Published online: 07 Mar 2023

AbstractforSafety and cardiometabolic efficacy of novel antidiabetic drugs | Full Text | References | PDF (218.9 KB) | EPUB

189 Views
0 CrossRef citations
0Altmetric

Review

Superior stroke prevention with angiotensin receptor blockers compared with other antihypertensive drugs

Steven G. Chrysant

Pages: 125-131

Published online: 09 Mar 2023

AbstractforSuperior stroke prevention with angiotensin receptor blockers compared with other antihypertensive drugs | Full Text | References | PDF (268 KB) | EPUB

98 Views
0 CrossRef citations
0Altmetric

Systematic Review and Meta-analysis

The risk of all-cause death with dapagliflozin versus placebo: a systematic review and meta-analysis of phase III randomized controlled trials

Hai-Bin Chen, Rong-Sen Meng, Yao-Lin Yang & Tian-Hao Yu

Pages: 133-140

Published online: 26 Feb 2023

175 Views
0 CrossRef citations
0Altmetric

Original Research

Article

Safety and tolerability of spesolimab in patients with ulcerative colitis

Marc Ferrante, Peter M Irving, Christian P Selinger, Geert D’Haens, Tanja Kuehbacher, Ursula Seidler, Savion Gropper, Thomas Haeufel, Sebastiano Forgia, Silvio Danese, Jochen Klaus & Brian G. Feagan for the spesolimab in UC phase II clinical trial investigators

Pages: 141-152

Published online: 31 Jul 2022

3860 Views
3 CrossRef citations
0Altmetric

Open Access

Article

Safety and effectiveness of empagliflozin and linagliptin fixed-dose combination therapy in Japanese patients with type 2 diabetes: final results of a one-year post-marketing surveillance study

Nobuya Inagaki, Takaaki Nishimoto, Yoichi Nishiya & Daisuke Nitta

Pages: 153-163

Published online: 16 Aug 2022

AbstractforSafety and effectiveness of empagliflozin and linagliptin fixed-dose combination therapy in Japanese patients with type 2 diabetes: final results of a one-year post-marketing surveillance study | Full Text | References | PDF (860.7 KB) | EPUB | Supplemental

3669 Views
0 CrossRef citations
0Altmetric

Open Access

Article

Pharmacovigilance regulatory actions by national pharmacovigilance centers in Arab countries following COVID-19 pandemic

Sameh A. Al-Zubiedi, Manal Younus, Sara Al-Khalidi, Magnus Ekilo & Thamir M. Alshammari

Pages: 165-174

Published online: 18 Aug 2022

AbstractforPharmacovigilance regulatory actions by national pharmacovigilance centers in Arab countries following COVID-19 pandemic | Full Text | References | PDF (1.3 MB) | EPUB

82 Views
0 CrossRef citations
0Altmetric

Article

Ocular adverse events associated with BRAF and MEK inhibitor combination therapy: a pharmacovigilance disproportionality analysis of the FDA adverse event reporting system

Shuohan Huang, Zihan Guo, Mengmeng Wang, Youjun She, Xuan Ye, Qing Zhai, Jiyong Liu & Qiong Du

Pages: 175-181

Published online: 10 Mar 2023

AbstractforOcular adverse events associated with BRAF and MEK inhibitor combination therapy: a pharmacovigilance disproportionality analysis of the FDA adverse event reporting system | Full Text | References | PDF (300.8 KB) | EPUB

2022 Views
2 CrossRef citations
0Altmetric

Open Access

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

Data mining study on adverse events of tirzepatide based on FAERS database

Yan Huo et al.

Article | Published online: 15 Jul 2024

Hypercalcemia in children induced by denosumab: a case report and an analysis of the FDA adverse event reporting system database

Yiyu Chen et al.

Article | Published online: 15 Jul 2024

Adverse drug events associated with fluorouracil use in patients with metastatic colorectal cancer: a real-world pharmacovigilance study based on the FDA adverse event reporting system

Ruiqi Zhao et al.

Article | Published online: 15 Jul 2024

Hemorrhagic events associated with tacrolimus: a real-world pharmacovigilance study

Haolin Teng et al.

Article | Published online: 15 Jul 2024

View all latest articles

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Expert Opinion on Drug Safety (Vol.22, Iss.2, 2023)

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?